Form 4: CalciMedica Officer Michael J. Dunn Reports Stock Option Grant
SEC Form 4 Filing
Michael J. Dunn, President and COO of CalciMedica, reports the acquisition of employee stock options.
Summary
- Michael J. Dunn, President and COO of CalciMedica, filed a Form 4 on April 22, 2024, reporting a transaction on March 28, 2024.
- The transaction involved the acquisition of 62,500 employee stock options with an exercise price of $4.16.
- These options vest in equal monthly installments over a four-year period following the grant date and expire on March 27, 2034.
- Following the reported transaction, Dunn directly owns 62,500 derivative securities.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to stock option grants, which is neither particularly positive nor negative.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to monitor management's alignment with shareholder interests.
Stakeholder Impact
- The granting of stock options aligns management's interests with those of shareholders by incentivizing them to increase the company's value.
Key Dates
| Date | Description |
|---|---|
| 03/28/2024 | Date of stock option grant. |
| 03/27/2034 | Expiration date of the stock options. |
| 04/22/2024 | Date Form 4 was filed. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.